To: M. Frank Greiffenstein who wrote (16855 ) 5/13/1998 8:02:00 PM From: Bonzo Read Replies (2) | Respond to
Trailing revenue has no value? Those are your words not mine. My point is this, I don't recall from any of your previous posts, nor those of most others, that the current valuation of TAVA was based on trailing revenues. And TAVA's trailing revenues were the reason you/they were buying. In fact Doc, you were one of the many who went through the exercise of predicting future revenues, based on remediation, CD sales and core business growth. What sticks in my craw (respectfully) is that once you sold, you revert to citing trailing revenues as your primary determination of TAVA's present value. As if TAVA suddenly has no future revenue growth. Yes at some point in time, probably within the next couple of quarters TAVA is going to have to put up or I am going to have to shut up. But you left the party early my friend its that simple. As long as you made a profit I'm happy for you. TAVA's business is proceeding from the "development stage" into full commercialization now. Think Biotech :-) Now is not the time to sell. Why truncate TAVA's future revenue growth after Q3 simply because you found TAVA's revenue disappointing? It met TAVA's expectations. Jenkins was "excited by the momentum" in Y2K. Perhaps yours, mine and the rest are too high? I believe you were at least 1-2 quarters too early with your dire assessment and sell. "The best is yet to come" Now where have you heard that before?
